Tonix Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.

About TNXP

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. 

CEO
Seth Lederman
CEOSeth Lederman
Employees
81
Employees81
Headquarters
Chatham, New Jersey
HeadquartersChatham, New Jersey
Founded
2007
Founded2007
Employees
81
Employees81

TNXP Key Statistics

Market cap
251.86M
Market cap251.86M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
420.73K
Average volume420.73K
High today
$19.95
High today$19.95
Low today
$18.37
Low today$18.37
Open price
$18.45
Open price$18.45
Volume
307.76K
Volume307.76K
52 Week high
$69.97
52 Week high$69.97
52 Week low
$6.76
52 Week low$6.76

Stock Snapshot

With a market cap of 251.86M, Tonix Pharmaceuticals(TNXP) trades at $19.70. The stock has a price-to-earnings ratio of -0.02.

As of 2026-01-22, Tonix Pharmaceuticals(TNXP) stock has fluctuated between $18.37 and $19.95. The current price stands at $19.70, placing the stock +7.2% above today's low and -1.3% off the high.

The Tonix Pharmaceuticals(TNXP)'s current trading volume is 307.76K, compared to an average daily volume of 420.73K.

During the past year, Tonix Pharmaceuticals(TNXP) stock moved between $6.76 at its lowest and $69.97 at its peak.

During the past year, Tonix Pharmaceuticals(TNXP) stock moved between $6.76 at its lowest and $69.97 at its peak.

People also own

Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.